# Mapping PCDC to FHIR

The following describes the mapping between the tables of PCDC and FHIR.

Where possible, using the latest data dictionaries (subsequent to v1.0)

PCDC_SUBJECT_ID and SUBMITTER_ID are common to all, therefore omitted for brevity.

DISEASE_PHASE and COURSE_TIMING are common to many tables, omitted for brevity.

Timing of events and observations is measured by subject's age in PCDC. Everything in FHIR is recorded by date/time. Omitting AGE_AT_xxxx for brevity.

Often, additional value choices are represented as XXXX_OTHER. This is like an extensible value set in FHIR. Omitted for brevity.

Properties (columns) are sometimes prefixed by the table abbreviation, for example AE_OUTCOME (Adverse Event Outcome). Below, these are written without the prefix (e.g., OUTCOME)

Anytime there is a coded value, there can be a system and version. For brevity, the system and version properties have been omitted.

## Subject Identifier

* PCDC_SUBJECT_ID

## Subject Characteristics

* HONEST_BROKER_SUBJECT_ID
* CONSORTIUM
* DATA_CONTRIBUTOR_ID
* STUDY_ID
* AGE_AT_ENROLLMENT
* TREATMENT_ARM
* DATA_SOURCE (OS)
* RANDOMIZED_STATUS (OS)
* ENROLLED_STATUS (AML)

NOTE: Disease Phase and Course Timing are combined in AML [dev] into one table, Time Period, with a type code (TIME_PERIOD_TYPE) that is either `Disease Phase` or `Course`

## Disease Phase Timing (Common to all)

* DISEASE_PHASE
* DISEASE_PHASE_NUMBER
* AGE_AT_DISEASE_PHASE
* YEAR_AT_DISEASE_PHASE

## Course Timing (Common to all)

* COURSE
* COURSE_NUMBER
* AGE_AT_COURSE_START
* AGE_AT_COURSE_END
* AGE_AT_TXASSIGN (OS)
* AGE_AT_COURSE_ANC_500 (AML)

## Off Protocol Therapy or Study

* AGE_OFF
* OFF_TYPE
* REASON_OFF

## Demographics

* SEX
* RACE
* ETHNICITY

## Medical History

* CONDITION
* CONDITION_TYPE (OS)
* CONDITION_STATUS (OS)

## Survival Characteristics

* LKSS
* AGE_LOST_TO_FOLLOW_UP (AML)
* CAUSE_OF_DEATH
* TRM_TYPE (OS)
* CAUSE_OF_DEATH_DETAIL (AML)
* CAUSE_OF_DEATH_RANKING

## Vitals and Anthropometrics

* MEASUREMENT_TYPE
* MEASUREMENT
* MEASUREMENT_NUMERIC
* MEASUREMENT_UNIT

## Function Test

* CATEGORY
* TEST
* RESULT
* RESULT_CATEGORICAL (OS)
* RESULT_NUMERIC
* RESULT_UNIT

## Laboratory Test

* TEST
* SPECIMEN
* METHOD (AML)
* RESULT_MODIFIER (AML)
* RESULT (OS)
* RESULT_NUMERIC
* RESULT_UNIT
* THRESHOLD_HIGH
* TRAUMATIC_TAP (AML)

## Genetic Analysis

* METHOD
* ISCN (AML)
* INDEPENDENT_ABERATIONS (AML)
* CELLS_IN_METAPHASE (AML)
* COMMON_NAME (AML)
* STATUS (AML)
* CHROMOSOME (AML)
* GENE1 (AML)
* GENE2 (AML)
* MUTATION_TYPE (AML)
* COPY_NUMBER_VARIATION (AML)
* COPY_NUMBER (AML)
* HGVS_CODING (AML)
* HGVS_PROTEIN (AML)
* MUTANT_ALLELE_FRACTION (AML)

## Tumor Characteristics (OS)

* DETECTION_METHOD
* TISSUE_TYPE
* TUMOR_CLASSIFICATION
* TUMOR_SITE
* LATERALITY
* SITE_WITHIN_BONE
* SKIP_TUMOR
* SKIP_MET_INVOLVEMENT
* LONGEST_DIAM_DIM1
* LONGEST_DIAM_DIM2
* LONGEST_DIAM_DIM3
* TUMOR_VOLUME
* FRACTURE_SITE
* DEPTH
* JOINT_INVOLVEMENT
* NODAL_INVOLVEMENT
* EXTENSION_SITE

* ## Histology

* HISTOLOGY (OS)
* HISTOLOGY_GRADE (OS)
* FAB_TYPE (AML)
* WHO_AML (AML)
* MPAL (AML)
* MLDS (AML)
* TAMDS (AML)
* SECONDARY_AML (AML)

## Disease Characteristics (AML)

* DISEASE_SITE
* DETECTION_METHOD
* CNS_DISEASE_STATUS
* MYELOID_SARCOMA
* MYELOID_SARCOMA_SITE

## Medication

* MEDICATION_START
* MEDICATION_END
* MEDICATION
* ADMINSTRATION_STATUS (AML)
* NORMALIZATION_BASIS (OS)
* NUMBER_DOSES (AML)
* TOTAL_DOSE_ADMINISTERED
* TOTAL_DOSE_INTENDED (AML)
* DOSE_UNITS

## Radiation Therapy

* RT_START
* RT_END
* TUMOR_CLASSIFICATION (OS)
* TISSUE_TYPE (OS)
* SITE
* LATERALITY (OS)
* ENERGY_TYPE (OS)
* RT_DOSE
* RT_UNIT
* NUM_FRACTION (OS)
* TRANSPOSITION_ORGAN (OS)

## Transfusion Medicine Procedure (AML)

* TYPE
* PRODUCT

## Cellular Immunotherapy (AML)

* TYPE

## Stem Cell Transplant (AML)

* SCT_TYPE
* STEM_CELL_SOURCE
* DONOR_RELATIONSHIP
* HLA_MATCH
* NUMBER_HLA
* NUMBER_MATCHES
* HLA_A_RESULT
* HLA_B_RESULT
* HLA_C_RESULT
* HLA_DRB1_RESULT
* HLA_DQ_RESULT
* CONDITIONING_TYPE
* PRIOR_TBI

## Biopsy and Surgical Procedures (OS)

* PROCEDURE_TYPE
* TUMOR_CLASSIFICATION
* TISSUE_TYPE
* PROCEDURE_SITE
* PROCEDURE_LATERALITY
* SURGERY_TYPE_LIMB
* AMPUTATION_TYPE
* RESECTION_TYPE
* RECONSTRUCTION_TYPE
* PROCEDURE_EXTENT
* MARGINS
* BIOPSY_TYPE
* MET_NON_LUNG_MGMT
* MET_LUNG_MGMT
* DISTANCE_MARGIN
* HEMIPELVECTOMY_TYPE
* HEMIPELVECTOMY_SITE
* INTRAOP_ADJUVANT

## Subject Response

* RESPONSE_CATEGORY (AML)
* RESPONSE
* NECROSIS (OS)
* NECROSIS_PCT (OS)
* BM_PCT_BLASTS_AT_RESPONSE (AML)
* BM_ANALYSIS_METHOD_AT_RESPONSE (AML)
* ANC_AT_RESPONSE (AML)
* ANC_THRESHOLD_AT_RESPONSE (AML)
* PLATELET_COUNT_AT_RESPONSE (AML)
* PLATELET_THRESHOLD_AT_RESPONSE (AML)

## Minimal Residual Disease (AML)

* METHOD
* RESULT
* RESULT_NUMERIC
* RESULT_UNIT
* SENSITIVITY
* SAMPLE_SOURCE
* MOLECULAR_MARKERS

## Adverse Events

* AE_START
* AE_RESOLVED
* CODE
* GRADE
* ATTRIBUTION
* ICU (AML)
* SUPPORTIVE_MEDICATION (AML)
* INTERVENTION (AML)
* INTERVENTION_STATUS (AML)
* PATHOGEN (AML)
* PATHOGEN_CONFIRMATION (AML)
* GVHD_ACUITY (AML) - graft versus host disease
* GVHD_ORGAN (AML)
* OUTCOME

## Secondary (Subsequent) Malignant Neoplasm

* ICD_O_MORPH (OS)
* ICD_O_TOP (OS)
* TREATMENT_RELATED (AML)
* MORPH_CODE (AML)
* TOP_CODE (AML)

## Patient Reported Outcomes Metadata (OS)

* STUDY_ID
* PRO_MEASURES
